CMPS
COMPASS Pathways plc · Healthcare · Biotechnology
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +30.0% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 60 | +9 | 28.76M | $406.90M | +13 | −4 |
| Q1 2026 | 52 | +2 | 25.39M | $140.32M | +6 | −4 |
| Q4 2025 | 49 | +2 | 17.79M | $122.72M | +2 | — |
| Q3 2025 | 11 | 0 | 9.36M | $53.63M | +1 | −1 |
| Q2 2025 | 8 | -1 | 4.28M | $11.98M | — | −1 |
| Q1 2025 | 8 | -1 | 5.73M | $16.40M | — | −1 |
| Q4 2024 | 9 | +1 | 7.15M | $27.03M | +1 | — |
| Q3 2024 | 7 | +1 | 11.59M | $73.00M | +1 | — |
| Q2 2024 | 6 | — | 9.78M | $59.07M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Millennium Management ✦ | 2.72M | +55.9% | $15.56M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 2 | ARK Investment Management ✦ | 2.12M | +28.6% | $12.15M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 3 | Two Sigma Investments ✦ | 1.08M | +838.4% | $6.16M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 1.03M | — | $5.90M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 1.03M | — | $5.90M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Morgan Stanley ✦ | 1.03M | — | $5.90M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Morgan Stanley ✦ | 1.03M | — | $5.90M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Morgan Stanley ✦ | 1.03M | — | $5.90M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Morgan Stanley ✦ | 1.03M | — | $5.90M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 951.20K | +347.0% | $5.45M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 678.79K | New | $3.89M | 0.0% | New | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passive) | 422.82K | +12.1% | $2.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passive) | 422.82K | +12.1% | $2.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | BlackRock ✦ (passive) | 422.82K | +12.1% | $2.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Goldman Sachs Group ✦ | 200.74K | — | $1.15M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | State Street Global Advisors ✦ (passive) | 80.04K | +231.9% | $458,606 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | Geode Capital Management ✦ (passive) | 62.96K | +127.9% | $360,772 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | JPMorgan Chase ✦ | 20.22K | — | $115,872 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | JPMorgan Chase ✦ | 20.22K | — | $115,872 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | JPMorgan Chase ✦ | 20.22K | — | $115,872 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | JPMorgan Chase ✦ | 20.22K | — | $115,872 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| D. E. Shaw & Co. | $3.89M | 0.0% |
Exited
| Citadel Advisors | $372,125 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 190 holders, 92.50M shares, $510.22M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.